Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Emmanuel Colombo

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Cells|July 1, 2020
Diversity of Tumor-Infiltrating, γδ T-Cell Abundance in Solid CancersGhita Chabab, Florence Boissière-Michot, Caroline Mollevi, et al.
Bulletin Du Cancer|August 6, 2014
[Breast surgeon role in the management of high-risk breast lesions]Pierre-Emmanuel Colombo, Anne Vincent-Salomon, Marie-Christine Chateau, et al.
Future Oncology (London, England)|February 5, 2014
Prognostic impact of the inclusion of uPA/PAI-1 tumor levels in the current adjuvant treatment decision-making for early breast cancerHaïdar Saadoun, Pierre-Jean Lamy, Simon Thezenas, et al.
Gynecologic Oncology|June 14, 2011
Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancerPierre-Emmanuel Colombo, Mahfoud Boustta, Sylvain Poujol, et al.
BMC Cancer|December 19, 2015
High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancersWilliam Jacot, Caroline Mollevi, Frédéric Fina, et al.
Frontiers in Oncology|February 7, 2022
Assessing Histology Structures by <i>Ex Vivo</i> MR Microscopy and Exploring the Link Between MRM-Derived Radiomic Features and Histopathology in Ovarian CancerMarion Tardieu, Yulia Lakhman, Lakhdar Khellaf, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 16, 2012
Ovarian carcinomatosis: how the radiologist can help plan the surgical approachStephanie Nougaret, Helen C Addley, Pierre Emmanuel Colombo, et al.
Breast Cancer Research and Treatment|July 8, 2017
Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2- pN0 early breast cancersMarie Viala, Marie Alexandre, Simon Thezenas, et al.
Molecular Oncology|January 8, 2014
Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapseStanislas du Manoir, Béatrice Orsetti, Rui Bras-Gonçalves, et al.
BMJ Open|December 2, 2022
Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing <i>Escherichia coli</i> in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)Christophe Taoum, Guillaume Carrier, Marta Jarlier, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Cells|July 1, 2020
Diversity of Tumor-Infiltrating, γδ T-Cell Abundance in Solid CancersGhita Chabab, Florence Boissière-Michot, Caroline Mollevi, et al.
Bulletin Du Cancer|August 6, 2014
[Breast surgeon role in the management of high-risk breast lesions]Pierre-Emmanuel Colombo, Anne Vincent-Salomon, Marie-Christine Chateau, et al.
Future Oncology (London, England)|February 5, 2014
Prognostic impact of the inclusion of uPA/PAI-1 tumor levels in the current adjuvant treatment decision-making for early breast cancerHaïdar Saadoun, Pierre-Jean Lamy, Simon Thezenas, et al.
Gynecologic Oncology|June 14, 2011
Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancerPierre-Emmanuel Colombo, Mahfoud Boustta, Sylvain Poujol, et al.
BMC Cancer|December 19, 2015
High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancersWilliam Jacot, Caroline Mollevi, Frédéric Fina, et al.
Frontiers in Oncology|February 7, 2022
Assessing Histology Structures by <i>Ex Vivo</i> MR Microscopy and Exploring the Link Between MRM-Derived Radiomic Features and Histopathology in Ovarian CancerMarion Tardieu, Yulia Lakhman, Lakhdar Khellaf, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 16, 2012
Ovarian carcinomatosis: how the radiologist can help plan the surgical approachStephanie Nougaret, Helen C Addley, Pierre Emmanuel Colombo, et al.
Breast Cancer Research and Treatment|July 8, 2017
Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2- pN0 early breast cancersMarie Viala, Marie Alexandre, Simon Thezenas, et al.
Molecular Oncology|January 8, 2014
Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapseStanislas du Manoir, Béatrice Orsetti, Rui Bras-Gonçalves, et al.
BMJ Open|December 2, 2022
Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing <i>Escherichia coli</i> in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)Christophe Taoum, Guillaume Carrier, Marta Jarlier, et al.
Pageof 10